- Nachrichtendetail
-
18.06.2024 14:11:13 - dpa-AFX: *NOVO NORDISK PRESENTS DATA FROM SEMAGLUTIDE CLINICAL TRIALS IN DIABETES, OBESITY & CKD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NOVO-NORDISK AS B DK 0,1 | A3EU6F | Xetra | 134,240 | 27.06.24 13:26:58 | -0,260 | -0,19% | 134,220 | 134,300 | 134,440 | 134,500 |
